BRCA1 VUS: A functional analysis to differentiate pathogenic from benign variants identified in clinical diagnostic panels for breast cancer

Genetic testing for susceptibility genes through next-generation sequencing (NGS) has become a widely used technique. Using this, a number of genetic variants have been identified, several of which are variants of unknown significance (VUS). These VUS can either be pathogenic or benign. However, sin...

Descripción completa

Detalles Bibliográficos
Autores principales: Lourenço, Rita Adubeiro, Lança, Miguel, Monteiro Gil, Octávia, Cardoso, Joana, Lourenço, Teresa, Pereira-Leal, José B., Rodrigues, António Sebastião, Rueff, José, Nunes Silva, Susana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10280555/
https://www.ncbi.nlm.nih.gov/pubmed/37232349
http://dx.doi.org/10.3892/mmr.2023.13023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10280555/
https://www.ncbi.nlm.nih.gov/pubmed/37232349
http://dx.doi.org/10.3892/mmr.2023.13023

Ejemplares similares